Focus Partners Advisor Solutions’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
3,182
-1,534
-33% -$708K 0.01% 405
2026
Q1
$2.26M Sell
4,716
-876
-16% -$449K 0.02% 324
2025
Q4
$3.14M Buy
5,592
+1,105
+25% +$627K 0.04% 226
2025
Q3
$2.56M Buy
4,487
+3,126
+230% +$1.36M 0.03% 286
2025
Q2
$427K Buy
1,361
+264
+24% +$79.3K 0.01% 721
2025
Q1
$334K Buy
1,097
+393
+56% +$132K 0.01% 722
2024
Q4
$234K Buy
+704
New +$239K ﹤0.01% 687

Other funds holding MEDP

Focus Partners Advisor Solutions's MEDP Position: Q2 2026 in Review

Focus Partners Advisor Solutions reduced its Medpace (MEDP) stake by 33% in Q2 2026, selling an estimated $708K and leaving 3,182 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #405.

Focus Partners Advisor Solutions first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.14M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Focus Partners Advisor Solutions held 3,182 shares of Medpace worth $1.69M as of Q2 2026.
  • Focus Partners Advisor Solutions sold 1,534 Medpace shares in Q2 2026, an estimated $708K.
  • Medpace made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q2 2026, its #405 holding.
  • Focus Partners Advisor Solutions first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Focus Partners Advisor Solutions's Medpace position peaked at $3.14M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q2 2026, filed 6 Aug 2026.